Skip to main content

Cumberland drug company raises $3M seed round to develop cannabis-derived lung treatment

RS BioTherapeutics uses CBD from hemp to reduce lung inflammation from COPD, COVID-19 and other diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.